Ринок медичних виробів зараз та в ІІ півріччі 2023 року

Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…

On October 26, 2023, the III International Pharmaceutical Forum “Global Pharm” was held in Astana. During the forum, a Memorandum of Cooperation was concluded between the Ministry of Health of the…